The effect of the Convention on International Trade in Endangered Species on scientific collections

The Convention on International Trade in Endangered Species (CITES) was conceived in the spirit of cooperation, with the aim of ensuring that the international trade in wild animals and plants, including all parts and derivatives, did not threaten their survival. However, concerns have been raised by scientists that CITES hinders the cross-border movement of scientific specimens. To our knowledge, no empirical analysis has been undertaken to demonstrate the existence of this effect. We test for a CITES effect on the collection record of orchids from Brazil and Costa Rica using the collection records of bromeliads, which are not covered by CITES, as a control. Highly significant effects are found in both countries.     

国家濒危物种红色名录的生物多样性保护意义

IUCN濒危物种红色名录与国家濒危物种红色名录都是物种灭绝风险的测度, 前者是全球性评估, 后者则是国别研究。IUCN濒危物种红色名录预警了全球物种的濒危状况, 为全球生物多样性研究提供了大数据; 国别红色名录确定了各国物种受威胁状况, 填补了前者的知识空缺, 两份名录互为补充。目前对国家濒危物种红色名录重视不够。基于如下原因, 应当重视国别濒危物种红色名录的意义: (1)国家是濒危物种保护的行为主体, 物种在一个国家的生存状况是确定其保护级别、开展濒危物种保育的依据; (2)对于仅分布于一个国家的特有物种来说, 其国别濒危物种红色名录等级即是其全球濒危等级; (3)对于跨国境分布的物种来说, 国别濒危物种红色名录等级则确定了该物种在本国的生存状况; (4)结合IUCN濒危物种红色名录, 国别濒危物种红色名录为建立跨国保护地、保护迁徙物种的栖息地与跨国迁徙洄游通道提供依据; (5)国别濒危物种红色名录所特有的“区域灭绝”等级, 反映了一个物种边缘种群在该国的区域灭绝, 恢复“区域灭绝”物种是该物种原分布国重引入保育工作的重点; (6)国别濒危物种红色名录提供了该国物种编目、分类、分布和生存状况的最新信息。然而, 国别濒危物种红色名录的重要性在许多情况下被忽视了。目前正值全球新冠肺炎大流行, 人们正在重新审视人与野生动物的关系。我国将修订有关野生动物保护与防疫法法律以及《国家重点保护野生动物名录》, 防控新的人与野生动物共患疾病再次暴发。对于确定国家重点保护野生动物物种名录来言, 物种受威胁程度是物种列为国家重点保护物种的特征之一。重视国别红色名录有特别的意义。     

Life history predicts risk of species decline in a stochastic world

Understanding what traits determine the extinction risk of species has been a long-standing challenge. Natural populations increasingly experience reductions in habitat and population size concurrent with increasing novel environmental variation owing to anthropogenic disturbance and climate change. Recent studies show that a species risk of decline towards extinction is often non-random across species with different life histories. We propose that species with life histories in which all stage-specific vital rates are more evenly important to population growth rate may be less likely to decline towards extinction under these pressures. To test our prediction, we modelled declines in population growth rates under simulated stochastic disturbance to the vital rates of 105 species taken from the literature. Populations with more equally important vital rates, determined using elasticity analysis, declined more slowly across a gradient of increasing simulated environmental variation. Furthermore, higher evenness of elasticity was significantly correlated with a reduced chance of listing as Threatened on the International Union for Conservation of Nature Red List. The relative importance of life-history traits of diverse species can help us infer how natural assemblages will be affected by novel anthropogenic and climatic disturbances.     

Reconciling global mammal prioritization schemes into a strategy

The huge conservation interest that mammals attract and the large datasets that have been collected on them have propelled a diversity of global mammal prioritization schemes, but no comprehensive global mammal conservation strategy. We highlight some of the potential discrepancies between the schemes presented in this theme issue, including: conservation of species or areas, reactive and proactive conservation approaches, conservation knowledge and action, levels of aggregation of indicators of trend and scale issues. We propose that recently collected global mammal data and many of the mammal prioritization schemes now available could be incorporated into a comprehensive global strategy for the conservation of mammals. The task of developing such a strategy should be coordinated by a super-partes, authoritative institution (e.g. the International Union for Conservation of Nature, IUCN). The strategy would facilitate funding agencies, conservation organizations and national institutions to rapidly identify a number of short-term and long-term global conservation priorities, and act complementarily to achieve them.     

Nuclear and mitochondrial DNA reveals isolation of imperilled grey nurse shark populations (Carcharias taurus)

Loss of sharks and other upper-trophic marine predators has sparked worldwide concern for the stability of ocean ecosystems. The grey nurse (ragged-tooth or sand tiger) shark ( Carcharias taurus ) is Vulnerable on a global scale, Critically Endangered in Australia and presumed extinct in parts of its historical range. We used 193 muscle and fin samples collected from six extant populations to assess global mtDNA and microsatellite diversity and the degree of global population genetic structure. Control region mtDNA diversity was low in every population, and two populations (eastern Australia and Japan) contained only a single mtDNA haplotype. Genetic signatures of recent losses of genetic variation were not yet apparent at microsatellite loci, indicating that this low mtDNA variation is not a result of anthropogenic population declines. Population differentiation was substantial between each population pair except Brazil and South Africa, F _ST values ranged from 0.050 to 0.699 and 0.100 to 1.00 for microsatellite and mitochondrial data respectively. Bayesian analysis clearly partitioned individuals into five of the populations from which they were sampled. Our data imply a low frequency of immigrant exchange among each of these regions and we suggest that each be recognized as a distinct evolutionary significant unit. In contrast to pelagic species such as whale shark and white shark that may cross ocean basins and where cooperative international efforts are necessary for conservation, grey nurse shark, like many coastal species, need to be managed regionally.     

Assessment of Hebei flora against the IUCN Red List Criteria in China

Some plants of Hebei Province in China are under threat from human activities, such as over-herding and over-exploitation of wild medicinal plants and industrial plants, etc. To identify the plants in danger in the province and to inspect the quality of the environment encompassing Beijing and Tianjin, a red list of the threatened flora of Hebei Province was produced by using the IUCN Red List Criteria (version 3.1) and its guidelines (version 6.2). Some 262 species were assessed and the results were as follows: (1) the threatened flora include 211 species, accounting for 7.95% of the total native vascular plants. Among them, 44 are Critically Endangered, 80 Endangered and 87 Vulnerable; (2) the destruction of the habitat caused by human activities and the actual or potential exploitation of the plants themselves were the main threat factors of Hebei flora; (3) most of the threatened plants are located in the western, northern and northeastern mountainous regions, namely the key regions of Hebei plant diversity; the endemic and regionally endemic species are severely threatened. Consequently, the assessment not only presented the threatened status of Hebei flora but also indicated the relatively fragile health status of the environment of Beijing and Tianjin. Thus, it is suggested that the application of the IUCN Red List Criteria at the regional level, as an index, could reflect the health status of the local ecosystem. In addition, more concrete measures are needed to conserve the plant diversity and the natural ecosystem of Hebei Province and even the whole region encompassing Beijing and Tianjin.     

Assessment of Hebei flora against the IUCN Red List Criteria in China

Some plants of Hebei Province in China are under threat from human activities,such as over-herding and over-exploitation of wild medicinal plants and industrial plants,etc.To identify the plants in danger in the province and to inspect the quality of the environment encompassing Beijing and Tianjin,a red list of the threatened flora of Hebei Province was produced by using the IUCN Red List Criteria (version 3.1) and its guidelines (version 6.2).Some 262 species were assessed and the results were as follows:(1) the threatened flora include 211 species,accounting for 7.95% of the total native vascular plants.Among them,44 are Critically Endangered,80 Endangered and 87 Vulnerable;(2) the destruction of the habitat caused by human activities and the actual or potential exploitation of the plants themselves were the main threat factors of Hebei flora;(3) most of the threatened plants are located in the western,northern and northeastern mountainous regions,namely the key regions of Hebei plant diversity;the endemic and regionally endemic species are severely threatened.Consequently,the assessment not only presented the threatened status of Hebei flora but also indicated the relatively fragile health status of the environment of Beijing and Tianjin.Thus,it is suggested that the application of the IUCN Red List Criteria at the regional level,as an index,could reflect the health status of the local ecosystem,In addition,more concrete measures are needed to conserve the plant diversity and the natural ecosystem of Hebei Province and even the whole region encompassing Beijing and Tianjin.     

Ecotypes of wild rooibos (Aspalathus linearis (Burm. F) Dahlg., Fabaceae) are ecologically distinct

Aspalathus linearis (Burm. F) Dahlg., Fabaceae is cultivated by small- and large-scale commercial farmers of the Cederberg and Bokkeveld Plateau in the Cape Floristic Region of South Africa, for the production of an herbal beverage called ‘rooibos’ or ‘rooibos tea’. Small-scale farmers also harvest A. linearis from the wild and market the tea as an organic and fair-trade certified product. However, little is known about the apparent ecotypes of wild A. linearis. We hypothesized that 1) rooibos ecotypes are ecologically distinct (occurring in different plant communities defined by environmental variables); 2) rooibos ecotypes are functionally distinct due to variance in water use efficiency; and 3) rooibos ecotypes are associated with threatened vegetation types/species, making populations of wild rooibos ecotypes worthy of conservation. Ecotypes of wild rooibos were identified based on plant habit and local knowledge. Plant communities were classified using Twinspan, environmental factors were tested as predictors of ecotype distribution and water use efficiency of ecotypes growing across a rainfall gradient was determined from foliar natural abundance of ¹³C. Wild rooibos was not generally associated with endangered vegetation types but was associated with plant species having endangered status. Wild rooibos occurred in four plant communities and comprised five wild rooibos ecotypes: shrub, tree, upright, salignus and prostrate types. Although some ecotypes clearly co-occurred, evidence is provided for habitat preference between the ecotypes: Prostrate and upright ecotypes occurred at higher elevations (> 400-600 m). Shrub ecotypes occurred at lower rainfall sites (< 200 mm p.a.) and the salignus ecotype occurred at higher rainfall sites (> 500 mm p.a.). Foliar ¹³C indicated greater water use efficiencies by ecotypes in relatively drier areas. The extent to which this is a plastic or inherent response requires further investigation. Considering that wild rooibos ecotypes differ both ecologically and possibly also functionally and genetically, it is concluded that populations of wild rooibos ecotypes should be considered as distinct and worthy of conservation. This distinctness should be considered when farmers apply for both harvesting and ploughing rights on land with wild rooibos ecotypes.     

The complete mitochondrial genome sequence of the world's largest fish,the whale shark (Rhincodon typus), and its comparison with those of related shark species

The whale shark (Rhincodon typus) is the largest extant species of fish, belonging to the order Orectolobiformes. It is listed as a “vulnerable” species on the International Union for Conservation of Nature (IUCN)'s Red List of Threatened Species, which makes it an important species for conservation efforts. We report here the first complete sequence of the mitochondrial genome (mitogenome) of the whale shark obtained by next-generation sequencing methods. The assembled mitogenome is a 16,875 bp circle, comprising of 13 protein-coding genes, two rRNA genes, 22 tRNA genes and a control region. We also performed comparative analysis of the whale shark mitogenome to the available mitogenome sequences of 17 other shark species, four from the order Orectolobiformes, five from Lamniformes and eight from Carcharhiniformes. The nucleotide composition, number and arrangement of the genes in whale shark mitogenome are the same as found in the mitogenomes of the other members of the order Orectolobiformes and its closest orders Lamniformes and Carcharhiniformes, although the whale shark mitogenome had a slightly longer control region. The availability of mitogenome sequence of whale shark will aid studies of molecular systematics, biogeography, genetic differentiation, and conservation genetics in this species.     

Case studies on the use of biotechnologies and on biosafety provisions in four African countries

This review is based on a study commissioned by the European Commission on the evaluation of scientific, technical and institutional challenges, priorities and bottlenecks for biotechnologies and regional harmonisation of biosafety in Africa. Biotechnology was considered within four domains: agricultural biotechnologies (‘Green’), industrial biotechnologies and biotechnologies for environmental remediation (‘White’), biotechnologies in aquaculture (‘Blue’) and biotechnologies for healthcare (‘Red’). An important consideration was the decline in partnerships between the EU and developing countries because of the original public antipathy to some green biotechnologies, particularly genetically modified organisms (GMOs) and food from GM crops in Europe. The study focus reported here was West Africa (Ghana, Senegal, Mali and Burkina Faso).The overall conclusion was that whereas high-quality research was proceeding in the countries visited, funding is not sustained and there is little evidence of practical application of biotechnology and benefit to farmers and the wider community. Research and development that was being carried out on genetically modified crop varieties was concentrating on improving food security and therefore unlikely to have significant impact on EU markets and consumers. However, there is much non-controversial green biotechnology such as molecular diagnostics for plant and animal disease and marker-assisted selection for breeding that has great potential application. Regarding white biotechnology, it is currently occupying only a very small industrial niche in West Africa, basically in the sole sector of the production of liquid biofuels (i.e., bio-ethanol) from indigenous and locally planted biomass (very often non-food crops). The presence of diffused small-scale fish production is the basis to develop and apply new (Blue) aquaculture technologies and, where the research conditions and the production sector can permit, to increase this type of production and the economy of this depressed areas. However, the problems bound to environmental protection must not be forgotten; priority should be given to monitor the risks of introduction of foreign species. Red biotechnologies potentially bring a vast domain of powerful tools and processes to achieve better human health, most notably improved diagnostics by molecular techniques, better targeting of pathogens and a better knowledge of their sensitivities to drugs to permit better treatment.Biosafety regulatory frameworks had been initiated in several countries, starting with primary biosafety law. However, disparate attitudes to the purpose of biosafety regulation (e.g., fostering informed decision-making versus ‘giving the green-light for a flood of GMOs’) currently prevent a needed consensus for sub-regional harmonisation. To date, most R&D funding has come from North America with some commercial interests from Asia, but African biotechnology workers expressed strong desire for (re-)engagement with interested parties from the European Union. Although in some of the visited countries there are very well qualified personnel in molecular biology and biosafety/regulation, the main message received is that human resources and capacity building in-house are still needed. This could be achieved through home-based courses and capacity-building including funds for post-degree research to motivate and retain trained staff.     

Development of health biotechnology in developing countries: Can private-sector players be the prime movers?

Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.